Fund profile
Tickers
FBTAX, FBTCX, FBTTX, FBTIX, FIJYX
Fund manager
Total assets
$1.80 bn
Liabilities
$117.09 mm
Net assets
$1.68 bn
Number of holdings
83.00
83 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV Abbvie Inc | 399.36 mm | 2.43 mm shares | 23.72 | Common equity | Long | USA |
AMGN AMGEN Inc. | 225.67 mm | 718.10 k shares | 13.41 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 138.40 mm | 146.80 k shares | 8.22 | Common equity | Long | USA |
Fidelity Securities Lending Cash Central Fund | 113.94 mm | 113.93 mm shares | 6.77 | Short-term investment vehicle | Long | USA |
CYTK Cytokinetics Inc | 62.91 mm | 805.17 k shares | 3.74 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 61.69 mm | 474.83 k shares | 3.66 | Common equity | Long | Denmark |
ALNY Alnylam Pharmaceuticals Inc | 59.22 mm | 342.49 k shares | 3.52 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 58.13 mm | 742.75 k shares | 3.45 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 42.76 mm | 598.73 k shares | 2.54 | Common equity | Long | USA |
ARGX Argen X SE | 39.92 mm | 104.90 k shares | 2.37 | Common equity | Long | Netherlands |
SRPT Sarepta Therapeutics Inc | 26.31 mm | 221.10 k shares | 1.56 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 25.44 mm | 338.48 k shares | 1.51 | Common equity | Long | USA |
VRDN Viridian Therapeutics Inc | 24.73 mm | 1.28 mm shares | 1.47 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 22.68 mm | 409.60 k shares | 1.35 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 22.39 mm | 495.16 k shares | 1.33 | Common equity | Long | Canada |
Fidelity Cash Central Fund | 21.89 mm | 21.89 mm shares | 1.30 | Short-term investment vehicle | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 21.02 mm | 576.30 k shares | 1.25 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 18.09 mm | 513.65 k shares | 1.07 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 17.78 mm | 223.63 k shares | 1.06 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 17.54 mm | 1.26 mm shares | 1.04 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 17.03 mm | 705.59 k shares | 1.01 | Common equity | Long | USA |
APGE Apogee Therapeutics Inc. | 15.75 mm | 470.12 k shares | 0.94 | Common equity | Long | USA |
ATXS Astria Therapeutics Inc | 13.94 mm | 1.07 mm shares | 0.83 | Common equity | Long | USA |
ACLX Arcellx Inc | 13.65 mm | 220.70 k shares | 0.81 | Common equity | Long | USA |
BRIDGEBIO PHARMA INC PIPE
|
13.50 mm | 393.76 k shares | 0.80 | Common equity | Long | USA |
STTK Shattuck Labs Inc | 13.20 mm | 1.40 mm shares | 0.78 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 12.84 mm | 399.89 k shares | 0.76 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 12.65 mm | 456.00 k shares | 0.75 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 11.57 mm | 53.40 k shares | 0.69 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics - Ordinary Shares | 11.45 mm | 204.96 k shares | 0.68 | Common equity | Long | Cayman Islands |
SPYRE THERAPEUTICS INC PIPE
|
11.20 mm | 455.17 k shares | 0.67 | Common equity | Long | USA |
ELVN Enliven Therapeutics Inc | 10.61 mm | 676.11 k shares | 0.63 | Common equity | Long | USA |
INSM Insmed Inc | 10.59 mm | 381.00 k shares | 0.63 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 10.10 mm | 566.30 k shares | 0.60 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 9.80 mm | 224.70 k shares | 0.58 | Common equity | Long | Cayman Islands |
ALXO Alx Oncology Holdings Inc | 9.36 mm | 649.30 k shares | 0.56 | Common equity | Long | USA |
TYRA Tyra Biosciences Inc | 8.11 mm | 604.90 k shares | 0.48 | Common equity | Long | USA |
FUSN Fusion Pharmaceuticals Inc | 7.51 mm | 646.71 k shares | 0.45 | Common equity | Long | Canada |
ITCI Intra-Cellular Therapies Inc | 7.45 mm | 110.60 k shares | 0.44 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 7.27 mm | 613.65 k shares | 0.43 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals Inc | 7.21 mm | 339.27 k shares | 0.43 | Common equity | Long | USA |
MORF Morphic Holding Inc | 6.89 mm | 217.51 k shares | 0.41 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 6.87 mm | 105.00 k shares | 0.41 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals Inc | 6.39 mm | 581.72 k shares | 0.38 | Common equity | Long | USA |
FUSION PHARMACEUTICALS INC PIPE
|
5.88 mm | 505.60 k shares | 0.35 | Common equity | Long | Canada |
SLRN Acelyrin Inc | 5.82 mm | 764.15 k shares | 0.35 | Common equity | Long | USA |
DIANTHUS THERAPEUTICS INC PIPE
|
5.47 mm | 302.97 k shares | 0.32 | Common equity | Long | USA |
ANNX Annexon Inc | 5.47 mm | 1.32 mm shares | 0.32 | Common equity | Long | USA |
SONOMA BIOTHERAPEUTICS INC SER B PFD PP | 5.43 mm | 1.97 mm shares | 0.32 | Preferred equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 5.41 mm | 230.00 k shares | 0.32 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 5.31 mm | 1.20 mm shares | 0.32 | Common equity | Long | USA |
T-KNIFE THERAPEUTICS INC SER B PC PP | 5.14 mm | 1.30 mm shares | 0.31 | Preferred equity | Long | USA |
TNGX Tango Therapeutics Inc | 4.78 mm | 406.87 k shares | 0.28 | Common equity | Long | USA |
NMRA Neumora Therapeutics Inc. | 4.57 mm | 306.90 k shares | 0.27 | Common equity | Long | USA |
AVTE Aerovate Therapeutics Inc | 4.33 mm | 224.00 k shares | 0.26 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 4.32 mm | 30.90 k shares | 0.26 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 4.16 mm | 260.10 k shares | 0.25 | Common equity | Long | USA |
CRGX CARGO Therapeutics Inc | 4.16 mm | 189.05 k shares | 0.25 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 4.05 mm | 374.19 k shares | 0.24 | Common equity | Long | USA |
DNTH Dianthus Therapeutics Inc | 3.76 mm | 197.70 k shares | 0.22 | Common equity | Long | USA |
TANGO THERAPEUTICS INC PIPE
|
3.73 mm | 317.85 k shares | 0.22 | Common equity | Long | USA |
LIFEMINE THERAPEUTICS INC SER C PP | 3.69 mm | 1.95 mm shares | 0.22 | Preferred equity | Long | USA |
BOUNDLESS BIO INC SER B PC PP | 3.37 mm | 3.70 mm shares | 0.20 | Preferred equity | Long | USA |
JANX Janux Therapeutics Inc | 3.35 mm | 391.59 k shares | 0.20 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics Inc | 3.35 mm | 632.26 k shares | 0.20 | Common equity | Long | USA |
WUGEN INC SER B PC PP | 3.29 mm | 580.28 k shares | 0.20 | Preferred equity | Long | USA |
SONOMA BIOTHERAPEUTICS INC SER B1 PFD PP | 3.28 mm | 1.05 mm shares | 0.20 | Preferred equity | Long | USA |
BRIGHT PEAK THERAPEUTICS SER B PC PP | 3.19 mm | 1.92 mm shares | 0.19 | Preferred equity | Long | Switzerland |
KARTOS THERAPEUTICS INC SERIES C PC PP | 3.01 mm | 530.69 k shares | 0.18 | Preferred equity | Long | USA |
RAPPORT THERAPEUTICS SER B PC PP | 2.60 mm | 1.43 mm shares | 0.15 | Preferred equity | Long | USA |
ALLK Allakos Inc | 2.44 mm | 1.92 mm shares | 0.14 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 1.85 mm | 526.70 k shares | 0.11 | Common equity | Long | USA |
TECTONIC THERAPEUTIC INC PIPE
|
1.69 mm | 136.30 k shares | 0.10 | Common equity | Long | USA |
IKNA Ikena Oncology Inc | 1.62 mm | 1.21 mm shares | 0.10 | Common equity | Long | USA |
FOG PHARMACEUTICALS INC SER D PC PP | 1.45 mm | 239.28 k shares | 0.09 | Preferred equity | Long | USA |
SYRE Spyre Therapeutics Inc. | 621.84 k | 24.00 k shares | 0.04 | Common equity | Long | USA |
AFFERENT PHARMACEUTICALS INC CONTINGENT VALUE RT 12/31/24
|
383.16 k | 1.92 mm shares | 0.02 | Common equity | Long | USA |
TREELINE BIOSCIENCES SERIES A PC PP | 371.28 k | 47.60 k shares | 0.02 | Preferred equity | Long | USA |
KYMR Kymera Therapeutics Inc | 298.30 k | 9.10 k shares | 0.02 | Common equity | Long | USA |
SCHOLAR ROCK HOLDING CORP WT 12/31/2025 PP
|
45.93 k | 6.00 k shares | 0.00 | Common equity | Long | USA |
AFFERENT PHARMACEUTICALS INC SER C PC PP | 19.16 | 1.92 mm shares | 0.00 | Preferred equity | Long | USA |
ENLIVEN THERAPEUTICS INC CVR (NON-TRADABLE)
|
7.40 | 739.73 k shares | 0.00 | Common equity | Long | USA |
ASTRIA THERAPEUTICS INC WT
|
2.48 | 247.63 k shares | 0.00 | Common equity | Long | USA |